👤 Riping Wu

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
1732
Articles
1210
Name variants
Also published as: Jiake Wu, Ming-Jiuan Wu, Siying Wu, Yijian Wu, Fong-Li Wu, Chih-Chung Wu, Jin'en Wu, Zixiang Wu, D P Wu, Zhongwei Wu, Haiping Wu, Geyan Wu, Qi-Zhu Wu, Jianjin Wu, Shwu-Yuan Wu, Su Wu, Xiaodi Wu, Changxin Wu, Kuen-Phon Wu, Zhiping Wu, Guofeng Wu, Xiaojun Wu, Qibing Wu, Cheng-Hsin Wu, Xiaoting Wu, Junhua Wu, Wenze Wu, Hong Wu, Yandi Wu, Zhong Wu, An-Chih Wu, Jianhui Wu, Xiaoke Wu, Zhenguo Wu, Jason H Y Wu, Selena Meiyun Wu, Yi-Mi Wu, Bing-Bing Wu, M Wu, Hui-Mei Wu, Danni Wu, Sijie Wu, Minqing Wu, Geng-ze Wu, Cheng-Hua Wu, Kun Wu, Shaofei Wu, Zhaoyang Wu, Qihan Wu, Kunling Wu, R Ryanne Wu, Mingxuan Wu, Hao Wu, Pei Wu, Wendy Wu, Yukang Wu, Douglas C Wu, Jingtao Wu, Guizhen Wu, Zhangjie Wu, Lili Wu, Jianwu Wu, Biaoliang Wu, Min-Jiao Wu, Huan Wu, Shengxi Wu, Fei-Fei Wu, Peih-Shan Wu, Guoqing Wu, Yu-Yuan Wu, Pei-Yu Wu, Jing Wu, Geting Wu, Lun-Gang Wu, Dongzhe Wu, G Wu, Junlong Wu, Jia-Jun Wu, Jiangyue Wu, Muzhou Wu, Junzhu Wu, Ray-Chin Wu, Jian-Qiu Wu, T Wu, Jianxiong Wu, Liping Wu, Haiwei Wu, Guoping Wu, Yong-Hao Wu, Jin-hua Wu, Yi Wu, You Wu, Chongming Wu, Qunzheng Wu, Xudong Wu, Liqiang Wu, Cuiling Wu, Kunfang Wu, Bian Wu, Limeng Wu, Jason Wu, Zhibing Wu, Shuying Wu, Caihong Wu, Naqiong Wu, Joseph C Wu, Huating Wu, Tianhao Wu, Zhi-Hong Wu, Congying Wu, Gaojun Wu, Dongping Wu, Chiao-En Wu, Li Wu, Haixia Wu, Yihang Wu, Shaoxuan Wu, Gen Wu, Fanchang Wu, Xiaorong Wu, Mingjie Wu, Mei Wu, Jiahao Wu, Jiapei Wu, Lingqian Wu, Jia Wu, Fangge Wu, Sen-Chao Wu, Yanhui Wu, Zhiqiang Wu, Shugeng Wu, Sarah Wu, Xuanqin Wu, Dongmei Wu, Caiwen Wu, Jiangdong Wu, Junjing Wu, Guihua Wu, Meini Wu, Yingbiao Wu, Rui Wu, Hua-Yu Wu, Bifeng Wu, Jingwan Wu, Lingling Wu, Junzheng Wu, Xinmiao Wu, Yi-Fang Wu, Yuyi Wu, Qinglin Wu, Yixuan Wu, Leilei Wu, Bin Wu, Tianqi Wu, Shiya Wu, Hui-Chen Wu, Jian Wu, Sijun Wu, Cong Wu, Yiwen Wu, Feng Wu, Xi-Ze Wu, Qiuji Wu, Alexander T H Wu, Semon Wu, Qinan Wu, Lai Man Natalie Wu, Zhuokai Wu, Ran Wu, Panyun Wu, Kui Wu, Yumei Wu, Xinrui Wu, Biwei Wu, Yueling Wu, Xing Wu, Hua Wu, Jiayi Wu, Yuen-Jung Wu, Bingjie Wu, Xiaoliang Wu, Matthew A Wu, Jin Wu, Juanjuan Wu, Qiuhong Wu, Hongfu Wu, Xiaoming Wu, Ming-Sian Wu, Ronghua Wu, Junduo Wu, Dandan Wu, Ming-Shiang Wu, Yuliang Wu, Ying-Ying Wu, Chaoling Wu, Guang-Liang Wu, De Wu, Yihua Wu, Yuanyuan Wu, Tsung-Jui Wu, Yulian Wu, Han Wu, Lipeng Wu, Zhihao Wu, Jiexi Wu, Anna H Wu, Yaqin Wu, Qiu Wu, Huazhen Wu, Shengru Wu, Chieh-Lin Stanley Wu, Xiahui Wu, Xiaoqian Wu, Jianli Wu, Jian-Yi Wu, Yun-Wen Wu, Qiuya Wu, Tsai-Kun Wu, Xinyin Wu, Guoyao Wu, Zhenfeng Wu, Guoli Wu, J W Wu, Bill X Wu, Zujun Wu, Jianliang Wu, Yuanshun Wu, Ling-Ying Wu, Zeng-An Wu, Jianrong Wu, Xue Wu, Ke Wu, Mengxue Wu, Cheng-Yang Wu, Jinghong Wu, Rongrong Wu, Ruolan Wu, Rong Wu, Kevin Zl Wu, Xiaohong Wu, Run Wu, Zaihao Wu, Chaowei Wu, Yu-Ke Wu, Xinjing Wu, Anyue Wu, Yun Wu, Xuan Wu, Meili Wu, Shu Wu, Wanxia Wu, Yi-No Wu, Chao-Liang Wu, Chengwei Wu, Y-W Wu, Pensee Wu, Zhao-Bo Wu, Guangxian Wu, Xiao Wu, Juanli Wu, Xinlei Wu, Changjie Wu, Sai Wu, Yujuan Wu, Jiawei Wu, Haoze Wu, Renlv Wu, Xiaoyang Wu, Yipeng Wu, Yuh-Lin Wu, Yu'e Wu, An-Hua Wu, Dan-Chun Wu, Meng-Chao Wu, Yuanhao Wu, Jer-Yuarn Wu, Qian-Yan Wu, Guangyan Wu, Huisheng Wu, Shuting Wu, Huijuan Wu, Long-Jun Wu, Alice Ying-Jung Wu, Xiru Wu, Lidi Wu, Zhenfang Wu, Yetong Wu, Disheng Wu, Huiwen Wu, Linmei Wu, Zhenzhou Wu, Yuhong Wu, Liang Wu, Liyan Wu, Kuan-Li Wu, Pei-Ting Wu, Xiao-Jin Wu, Terence Wu, Lifeng Wu, Shujuan Wu, Gang Wu, Szu-Hsien Wu, Xue-Mei Wu, Yan-ling Wu, Lingyan Wu, Xiaokang Wu, Yih-Jer Wu, Xinghua Wu, Chunfu Wu, Yingxia Wu, Rongling Wu, Xifeng Wu, Jinhua Wu, Sihan Wu, Ming-Yue Wu, Shiyang Wu, K D Wu, Jinmei Wu, Luyan Wu, Shin-Long Wu, Shuai Wu, Zhipeng Wu, Guangzhen Wu, Zhixiang Wu, Longting Wu, Zhengsheng Wu, Xiaoqiong Wu, Yaoxing Wu, Yuqin Wu, Yudan Wu, Zoe Wu, Hongting Wu, Chi-Jen Wu, R Wu, Meina Wu, Zhongqiu Wu, Dengying Wu, Anke Wu, Cheng-Jang Wu, Hsi-Chin Wu, Shufang Wu, Yongjiang Wu, Yuan-de Wu, Sihui Wu, Qi Wu, Wenhui Wu, Fenfang Wu, K S Wu, Nana Wu, Jianzhi Wu, Lin-Han Wu, Zhen Wu, Jinjun Wu, Chen-Lu Wu, Haiyan Wu, Jing-Fang Wu, Yihui Wu, Qiqing Wu, Zhengzhi Wu, Dai-Chao Wu, Zhenyan Wu, Wen-Jeng Wu, Guanming Wu, Yongqun Wu, Sean M Wu, Hei-Man Wu, Su-Hui Wu, Diana H Wu, Ben J Wu, Pingxian Wu, Chew-Wun Wu, Yillin Wu, Jiang-Bo Wu, Xiaobing Wu, Jerry Wu, Siming Wu, Zijun Wu, Daqing Wu, Yu-Hsuan Wu, Lichao Wu, Zhimin Wu, Qijing Wu, Daxian Wu, Zhaoyi Wu, Z Wu, Tong Wu, Cheng-Chun Wu, Shusheng Wu, Tracy Wu, D Wu, Ting-Ting Wu, Xiao-Yan Wu, Lan Wu, J Wu, Changchen Wu, Qi-Fang Wu, Changwei Wu, Liangyan Wu, Liufeng Wu, Kan Wu, Eugenia Wu, Mingming Wu, Xiaolong Wu, Chunru Wu, Zhaofei Wu, Shenhao Wu, Li-Peng Wu, Yuna Wu, Minna Wu, Justin Che-Yuen Wu, Buling Wu, Wutian Wu, Chengyu Wu, Yuwei Wu, Guixin Wu, Haijing Wu, Hei Man Wu, Xiao-Hui Wu, Qiuchen Wu, Junfei Wu, Wenda Wu, Linyu Wu, Xiaofeng Wu, Yung-Fu Wu, Mengbo Wu, Zhenling Wu, Zuping Wu, Maoqing Wu, Chun-Chieh Wu, Julian Wu, Binbin Wu, Xiaohui Wu, Qian Wu, Xinchun Wu, Shuisheng Wu, Xueqing Wu, Linxiang Wu, Bo Wu, Moxin Wu, Xiao-Cheng Wu, Anzhou Wu, Shuyi Wu, Jiahui Wu, Meiqin Wu, Shihao Wu, Jer-Yuan Wu, Wen-Shu Wu, Wudelehu Wu, Ruonan Wu, Song Wu, Yulin Wu, De-Fu Wu, Hongyu Wu, Yurong Wu, Zixuan Wu, Shih-Ying Wu, Chih-Hsing Wu, Chengrong Wu, Yinghao Wu, Yuanzhao Wu, Baochuan Wu, Wenjie Wu, Ziliang Wu, Liuting Wu, Chia-Ling Wu, Y Q Wu, Man Wu, Na Wu, Wutain Wu, Chenyang Wu, Jinyu Wu, Selwin K Wu, Ping Wu, Lorna Wu, D I Wu, Yi-Cheng Wu, Jianzhong Wu, Xiaoyun Wu, Zhourui Wu, Li-Jun Wu, Xinhe Wu, Zhi-Wei Wu, Yinan Wu, Xinyan Wu, Xin Wu, Ting-Feng Wu, Yawei Wu, Shixin Wu, Hong-Mei Wu, Xiaojin Wu, Yiqun Wu, Tsung-Teh Wu, Jiarui Wu, Qi-Nian Wu, Ju Wu, Kai-Yue Wu, Pengjie Wu, Xi-Chen Wu, Zhe Wu, Shaoping Wu, Zhou Wu, Han-Jie Wu, Haijiang Wu, Weijie Wu, Xiaojie Wu, Hongfei Wu, Yi-Ying Wu, Zhentian Wu, Ze Wu, Kai-Hong Wu, Yuting Wu, Minyao Wu, Xueyan Wu, Shinan Wu, Feifei Wu, Yonghui Wu, Haoxuan Wu, Yanzhi Wu, Yiyi Wu, Dong Wu, Guohao Wu, Wenjing Wu, Shibo Wu, Wenqian Wu, Tian Wu, Tiantian Wu, Hai-Yan Wu, Chong Wu, Hongxian Wu, Daoyuan Wu, Zongfu Wu, Ling Wu, Yuxiang Wu, Xilong Wu, Yuyu Wu, Huijian Wu, Fengming Wu, Zong-Jia Wu, Guorong Wu, Chuanhong Wu, Choufei Wu, Junfang Wu, Chi-Chung Wu, Xingwei Wu, Ling-Fei Wu, Xiaoqing Wu, Xinyang Wu, Xiaomin Wu, Yili Wu, Hong-Fu Wu, Shao-Ming Wu, Thomas D Wu, Lizhen Wu, Yuanming Wu, Hsien-Ming Wu, Jian Hui Wu, Litong Wu, Yuxian Wu, Weihua Wu, Lei Wu, C Wu, Wei Wu, Yu-E Wu, Qiulian Wu, Mei-Hwan Wu, Yuexiu Wu, Shaoze Wu, Zilong Wu, Chi-Hao Wu, Baojin Wu, Chao Wu, Yao Wu, Ya Wu, Do-Bo Wu, Wenjun Wu, Zhongren Wu, Nini Wu, Michael C Wu, Ning Wu, Jie Wu, Ming J Wu, Yi-Syuan Wu, Limei Wu, Zhenzhen Wu, Tianwen Wu, Wen-Chieh Wu, Yunhua Wu, Junfeng Wu, Shunan Wu, Junqi Wu, Jianing Wu, Honglin Wu, Maureen Wu, Yexiang Wu, Yan-Hua Wu, Mengjun Wu, Y H Wu, Mingxing Wu, Liuying Wu, Suhua Wu, Xiaomeng Wu, Shyh-Jong Wu, Tung-Ho Wu, Hongliang Wu, Wenxian Wu, Xuekun Wu, Ed Xuekui Wu, Wenqiang Wu, Chuang Wu, Jingyi Wu, Duojiao Wu, Xueyuan Wu, Ji-Zhou Wu, Lianqian Wu, Gaige Wu, Qing-Qian Wu, Haihu Wu, Xiushan Wu, Xueyao Wu, Tingchun Wu, Yafei Wu, Lingxi Wu, R-J Wu, Weidong Wu, Re-Wen Wu, Zhidan Wu, Peiyao Wu, Xuemei Wu, Chen Wu, Yiting Wu, Kerui Wu, Lihong Wu, Shiqi Wu, Liren Wu, Xiuhua Wu, Beili Wu, Yongqi Wu, Ruihong Wu, Huini Wu, Guang-Long Wu, Lingyun Wu, Po-Chang Wu, Wenxue Wu, Qinghua Wu, Ru-Zi Wu, Wenlin Wu, Changjing Wu, Xiexing Wu, J Y Wu, Jianping Wu, Guanggeng Wu, W J Wu, Zhichong Wu, Di Wu, Shaoyu Wu, Xiaotong Wu, Junyong Wu, Hui Wu, Shengde Wu, Hongyan Wu, Mengyuan Wu, Yutong Wu, Zheming Wu, Yiping Wu, Dapeng Wu, Guiping Wu, Wen-Hui Wu, Bing Wu, Wen-Sheng Wu, Yunpeng Wu, Li-Ling Wu, Xiao-Yuan Wu, Baiyan Wu, Qiu-Li Wu, Ying Wu, Xiao-Ye Wu, Da-Hua Wu, Hsing-Chieh Wu, Hui-Xuan Wu, Chieh-Jen Wu, Pengning Wu, Sichen Wu, S F Wu, Mengying Wu, Jia-En Wu, Ming-Der Wu, Qi-Jun Wu, Weida Wu, Guo-Chao Wu, Zhenyong Wu, Qi-Biao Wu, Yangfeng Wu, Lijie Wu, Zhiye Wu, Jihui Wu, Qianqian Wu, JieQian Wu, Zhengliang L Wu, Jingyun Wu, Xiaoman Wu, Ruohao Wu, Zhengfeng Wu, Yiyang Wu, Xiao-Jun Wu, Lizi Wu, Qiang Wu, J-Z Wu, Guangjie Wu, Pengfei Wu, Jundong Wu, Jianying Wu, Beier Wu, Meng-Ling Wu, Lingxiang Wu, Jamie L Y Wu, Keija Wu, Xilin Wu, Yanhua Wu, An-Li Wu, Yi-Ming Wu, Chengbiao Wu, Huanghui Wu, Dong-Feng Wu, Kunsheng Wu, Zhengcan Wu, Yuxin Wu, Kun-Rong Wu, Dong-Fang Wu, Guanxian Wu, Sensen Wu, Guifen Wu, Yifeng Wu, Tzu-Chun Wu, Pin Wu, Qingping Wu, R M Wu, Mian Wu, S J Wu, Haisu Wu, Senquan Wu, Jingjing Wu, Cheng Wu, Meng Wu, Geping Wu, Yu Wu, Yumin Wu, Xia Wu, William Ka Kei Wu, Xian-Run Wu, Juan Wu, Meng-Hsun Wu, Pei-Ei Wu, Yingying Wu, S M Wu, Xiangwei Wu, Guangrun Wu, Liuxin Wu, Yangyu Wu, Jia-Hui Wu, Jin-Zhen Wu, S L Wu, Shaohuan Wu, June K Wu, Yanli Wu, Haishan Wu, H Wu, Zhou-Ming Wu, Deqing Wu, Tao Wu, Dong-Bo Wu, Binxin Wu, Yalan Wu, Xiangxin Wu, Xueji Wu, Hongxi Wu, Zhonghui Wu, Jiaxi Wu, Tianzhi Wu, Meiqi Wu, Yan-Jun Wu, Weiwei Wu, Lijuan Wu, Jianming Wu, Tingqin Wu, P L Wu, Yih-Ru Wu, Lanlan Wu, Jianjun Wu, Jianguang Wu, An-Xin Wu, Xingjie Wu, Jianzhang Wu, Xianan Wu, Wei-Ping Wu, Haoan Wu, Fang-Tzu Wu, Zhongjun Wu, Wenwen Wu, Xi Wu, Teng Wu, Xiaoling Wu, Mengjuan Wu, Wen Wu, Yifan Wu, Yang Wu, Qianhu Wu, Shenyue Wu, Wu-Tian Wu, Qianwen Wu, Ye Wu, Gui-Qin Wu, Lixing Wu, Grace F Wu, Xing-Ping Wu, Ming Wu, Lisha Wu, Yanchuan Wu, Siqi Wu, Yuming Wu, Yuan Wu, I H Wu, Yu-Ting Wu, Hailong Wu, Minghua Wu, Zhenlong Wu, B Wu, Fang Wu, Guanzhong Wu, Liqun Wu, Guifu Wu, Chris Y Wu, Zhikang Wu, Qi-Yong Wu, Qingshi Wu, Zhao-Yang Wu, Chih-Ching Wu, Man-Jing Wu, Jun Wu, Jinhui Wu, Jincheng Wu, Linhong Wu, Hung-Tsung Wu, Tangchun Wu, Xinglong Wu, Zhen-Yang Wu, Ma Wu, Yin Wu, Dongyan Wu, Jiu-Lin Wu, Yong Wu, Yan Wu, Weizhen Wu, Changyu Wu, Fanggeng Wu, Dishan Wu, Yue Wu, Yi-Long Wu, Ge-ru Wu, Jinqiao Wu, Jing-Wen Wu, Zhongyang Wu, Lifang Wu, Sheng-Li Wu, Jia-Wei Wu, Songfen Wu, Yihan Wu, Kebang Wu, Wenyong Wu, Cai-Qin Wu, Yilong Wu, Yanan Wu, Hsiu-Chuan Wu, Xueqian Wu, Yen-Wen Wu, Paul W Wu, Xing-De Wu, Ying-Ting Wu, Mingfu Wu, Yucan Wu, Na-Qiong Wu, Linzhi Wu, Jinze Wu, Xuhan Wu, H J Wu, Ruize Wu, Dirong Wu, Chung-Yi Wu, Yaohong Wu, Jianyi Wu, Jugang Wu, Jiao Wu, Liang-Huan Wu, Xueling Wu, Ruying Wu, Gen Sheng Wu, Zhaoyuan Wu, Shiwen Wu, Andong Wu, Yu-Ling Wu, Hsan-Au Wu, Jia-Qi Wu, Yanting Wu, Xihai Wu, Lulu Wu, Xuxian Wu, Xiaomei Wu, Jingyue Wu, Shuihua Wu, Ren Wu, S Wu, Yupeng Wu, Haoming Wu, Samuel M Wu, Fan Wu, Yuesheng Wu, Yihe Wu, Tiange Wu, Shuang Wu, Jiayu Wu, Chia-Lung Wu, Shengnan Wu, Yaojiong Wu, Y Y Wu, Zhuoze Wu, Y Wu, Zimu Wu, Depei Wu, Yi-Hua Wu, Yanyan Wu, Haiyun Wu, Min Wu, Wenjuan Wu, Jinfeng Wu, Guangxi Wu, Junjie Wu, Yawen Wu, Pinglian Wu, Hui-Hui Wu, Xunwei Wu, Xuefeng Wu, Constance Wu, Depeng Wu, Dianqing Wu, Qibiao Wu, Nan Wu, Hao-Tian Wu, Hanyu Wu, Xiaojiang Wu, San-pin Wu, Cheng-Jun Wu, Xiaofan Wu, Xiwei Wu, Shi-Xin Wu, Shao-Guo Wu, Sunyi Wu, Yueheng Wu, Chengqian Wu, Kuixian Wu, Guanyi Wu, Xin-Xi Wu, Qiuxia Wu, Danhong Wu, Zhong-Jun Wu, He Wu, Siyi Wu, Xiangsheng Wu, Lanxiang Wu, Kaili Wu, Liting Wu, Ping-Hsun Wu, Zheng Wu, Wen-Ling Wu, Jiang-Nan Wu, Huanlin Wu, Yongfei Wu, Catherine A Wu, Leslie Wu, Shuo Wu, Peng-Fei Wu, Cho-Kai Wu, Meng-Han Wu, Hon-Yen Wu, Anguo Wu, Yuguang Philip Wu, Hai-Yin Wu, Yicheng Wu, Xiaolang Wu, Yujie Wu, Qing Wu, V C Wu, Haomin Wu, Xingdong Wu, Hengyu Wu, Jiang Wu, Xiaoli Wu, Chengxi Wu, Junyi Wu, Ling-qian Wu, William K K Wu, Chun Wu, Lesley Wu, Niting Wu, Jiayuan Wu, Xueying Wu, Yingning Wu, S-F Wu, David Wu, Mei-Na Wu, Joshua L Wu, Jin-Shang Wu, Guanzhao Wu, Jianqiang Wu, Runda Wu, Li-Hsien Wu, June-Hsieh Wu, Rongjie Wu, Huazhang Wu, Huanwen Wu, Xiu-Zhi Wu, Yanran Wu, Xianfeng Wu, Weibin Wu, Xuanshuang Wu, Yan Yan Wu, G X Wu, Chien-Ting Wu, Li-Na Wu, Runpei Wu, Jiaqi Wu, Qinfeng Wu, Chia-Chang Wu, Yueming Wu, Renhai Wu, Siyu Wu, Baojian Wu, Yi-Xia Wu, Wei-Yin Wu, C-H Wu, Renrong Wu, Chuan-Ling Wu, Xinran Wu, Fengying Wu, Qiuliang Wu, Guanhui Wu, Jinjie Wu, Wei-Chi Wu, Wei-Xun Wu, Meng-Na Wu, Lin Wu, Wan-Fu Wu, Jiajing Wu, Colin Chih-Chien Wu, Yajie Wu, Qiaowei Wu, Yaru Wu, Xiaoping Wu, Xue-Yan Wu, Weijun Wu, Mengchao Wu, Boquan Wu, Zelai Wu, Chunyan Wu, Pei-Wen Wu, Guojun Wu, Yichen Wu, Ming-Tao Wu, Hsueh-Erh Wu, Guang-Bo Wu, Zhi-Yong Wu, Chia-Zhen Wu, Kay L H Wu, Yong-Hong Wu, Anping Wu, Jiahang Wu, Xiaobin Wu, Ching-Yi Wu, Linzhen Wu, Xiaoxing Wu, Haidong Wu, Zhen-Qi Wu, Mark N Wu, Jianmin Wu, Guanrong Wu, Xianpei Wu, Yanchun Wu, Dongsheng Wu, An-Dong Wu, Ren-Chin Wu, Yuchen Wu, Mengna Wu, Lijun Wu, Zhuanbin Wu, Yanjing Wu, Haodi Wu, Lun Wu, Si-Jia Wu, Yongfa Wu, Hai-Ping Wu, Ximei Wu, Wenyu Wu, Xiangping Wu, L-F Wu, Yixia Wu, Yiran Wu, Haiying Wu, Yanhong Wu, Xiayin Wu, Yushun Wu, Yali Wu, Qitian Wu, Xiaofu Wu, Qin Wu, Jiamei Wu, Xiaoyong Wu, Qiong Wu, Xiaoying Wu, Wujun Wu, N Wu, Peiyi Wu, Yongmei Wu, Xiaojing Wu, Yizhou Wu, Dan Wu, Wen-Qiang Wu, Anshi Wu, Junqing Wu, Xiao-Yang Wu, Zhaoxia Wu, Liyang Wu, Hongke Wu, Mengqiu Wu, Peng Wu, Haibin Wu, Ding Lan Wu, Lecheng Wu, Yingzhi Wu, Kejia Wu, Anyi Wu, Junshu Wu, Jianxin Wu, Deguang Wu, Jiaxuan Wu, W Wu, Justin C Y Wu, Jiong Wu, Yu-Chih Wu, Qinglan Wu, Xinyi Wu, Diana Wu, Zhongluan Wu, Xuefen Wu, Yanqiong Wu, Shengming Wu, Jian-Lin Wu, Donglin Wu, Daren Wu, Lintao Wu, Xiaodong Wu, Chang-Jiun Wu, Chunshuai Wu, Irene X Y Wu, Yaping Wu, Yangna Wu, Xiping Wu, Zongheng Wu, Chia-Chen Wu, Wenyi Wu, Yansheng Wu, Shaojun Wu, Aimin Wu, Caisheng Wu, Xu Wu, Zhongchan Wu, Yaohua Wu, Fei Wu, Qinyi Wu, Yibo Wu, Zhengyu Wu, Yadi Wu, Hang Wu, L Wu, Mingjun Wu, Yuetong Wu, Wen-Juan Wu, Guangming Wu, Lingzhi Wu, Tingting Wu, Zhuzhu Wu, Yuanbing Wu, Zhong-Yan Wu, Cuiyan Wu, Colin O Wu, Baoqin Wu, Shuyan Wu, Hongmei Wu, Guangsen Wu, Xiaolin Wu, An Guo Wu, Kailang Wu, Chien-Sheng Wu, Chun-Hua Wu, Jemma X Wu, Wenqi Wu, Quanhui Wu, Qing-Wu Wu, Yanxiang Wu, Jiajin Wu, Yuan Kai Wu, Qiao Wu
articles
Satomi Minato-Inokawa, Ayaka Tsuboi-Kaji, Mari Honda +6 more · 2025 · Scientific reports · Nature · added 2026-04-24
We tested whether elevated 1 h post-load glucose (1hPG) was associated with decreased leg fat (relative to body fat) and serum concentrations of lipoprotein lipase (LPL), a rate-limiting enzyme for li Show more
We tested whether elevated 1 h post-load glucose (1hPG) was associated with decreased leg fat (relative to body fat) and serum concentrations of lipoprotein lipase (LPL), a rate-limiting enzyme for lipid storage in subcutaneous leg fat. Body fat mass and distribution, as measured by DXA, surrogate measures of insulin sensitivity, and insulin secretion inferred from serum insulin kinetics during a 75-g oral glucose tolerance test, as well as serum adipokines and LPL, were assessed in 164 Japanese female university students and 94 middle-aged parents. They all had normal glucose tolerance. Students provided their birth weight. Elevated 1hPG was found in 6% of daughters and 22% of parents. Multivariate logistic regression analyses revealed that log insulinogenic index (IGI) (OR: 0.031, 95% CI 0.003-0.30, p = 0.003) and serum LPL (OR: 0.90, 95% CI 0.83-0.98, p = 0.01) were associated with elevated 1hPG independently of serum adiponectin and birth weight in young Japanese. In middle-aged Japanese, the ratio of leg fat to body fat (OR: 0.66, 95% CI 0.44-0.97, p = 0.03), log IGI (OR: 0.002, 95% CI 0.00003-0.07, p = 0.001), and Matsuda index (OR: 0.67, 95% CI 0.47-0.96, p = 0.03) were related to elevated 1hPG independently of fat mass index, the ratio of trunk fat to body fat, LPL, and homeostasis model assessment insulin resistance. A decreased amount of leg fat in middle-aged Japanese with elevated 1hPG may be explained hypothetically by a prolonged deficiency of LPL. Show less
📄 PDF DOI: 10.1038/s41598-025-21340-8
LPL
Zhaowei Zhu, Rui Kuang, Shouwen Su +9 more · 2025 · Cellular & molecular biology letters · BioMed Central · added 2026-04-24
Phenotypic transformation of Schwann cells (SCs) plays a crucial role in nerve regeneration. Previous studies have demonstrated that Runx2 significantly influences the biological behavior of SCs. None Show more
Phenotypic transformation of Schwann cells (SCs) plays a crucial role in nerve regeneration. Previous studies have demonstrated that Runx2 significantly influences the biological behavior of SCs. Nonetheless, the regulatory mechanisms that govern its epigenetic regulation are not yet fully elucidated. To facilitate this investigation, an adenovirus for the overexpression of Runx2 was constructed. Healthy adult Sprague-Dawley rats, weighing between 100 and 150 g and irrespective of sex, were randomly selected for the study. After establishing a model of sciatic nerve crush injury, tissue samples were harvested for histological analysis at both 4 and 7 days post-injury. In vitro, an Runx2-overexpressing SC line was established. Thorough analysis of transcriptome data, coupled with CUT&Tag sequencing of histones and transcription factors in SCs following Runx2 overexpression, was conducted. Additionally, single-cell RNA sequencing data from GSE216665 were incorporated to elucidate the mechanistic role of Runx2. The findings were subsequently validated through dual-luciferase assays. Following nerve crush injury, Runx2-positive SCs were identified at the injury site. Through comprehensive multiomics analysis, we discovered that lipid metabolism was disrupted in Runx2-overexpressing SCs. Further investigation established a detailed super-silencer landscape in these cells, revealing that elevated Runx2 levels form a super-silencer within the transcriptional regulatory region of the Lpl gene, thereby downregulating Lpl expression. Runx2 can modulate the biological behavior of SCs by forming super-silencers that interfere with the expression of lipid metabolism genes, such as Lpl, thereby altering the metabolic capacity of SCs. Show less
📄 PDF DOI: 10.1186/s11658-025-00796-6
LPL
Zhen Guo, Jing Su, Lu Liu +8 more · 2025 · Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · Elsevier · added 2026-04-24
Precise differential diagnosis between lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) and marginal zone lymphoma (MZL) remains a challenging issue because of overlapping clinicopath Show more
Precise differential diagnosis between lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) and marginal zone lymphoma (MZL) remains a challenging issue because of overlapping clinicopathological and immunophenotypic features. In the present study, the differential diagnostic potential of CD180 was assessed by determining its expression patterns in patients with MZL and LPL/WM through flow cytometry. The results indicated that LPL/WM cases exhibited a complete absence of CD180 expression on malignant B cells, whereas MZL cases showed robust CD180 expression (P < .001). Receiver operating characteristic analysis demonstrated that CD180 expression percentage showed optimal diagnostic accuracy in LPL/WM and MZL cases (area under the curve = 0.998, sensitivity = 100%, and specificity = 98.0%), with a further improvement in differentiation potential by the CD180 mean fluorescence intensity ratio (lymphocytes/monocytes) of ≤ 0.47 (area under the curve = 0.937). Moreover, although the MYD88 Show less
no PDF DOI: 10.1016/j.modpat.2025.100919
LPL
Menglu Zhang, Liping Yan, Kuixian Wu +5 more · 2025 · Journal of dairy science · added 2026-04-24
The size of fat globules in ruminant milk to some extent affects the nutritional quality of dairy products and plays potential roles in infant and adult health. Lipid droplets (LD) in mammary epitheli Show more
The size of fat globules in ruminant milk to some extent affects the nutritional quality of dairy products and plays potential roles in infant and adult health. Lipid droplets (LD) in mammary epithelial cells are the precursors of milk fat globules (MFG). However, it is unclear what happens to proteins during the transformation process from LD to MFG, and little is known about the regulation of LD diameter in vivo. In this study, 12 mid-lactation Saanen dairy goats were randomly divided into 2 groups: a control group fed a basal diet and an experimental group fed a basal diet supplemented with CLA at 90 g/d. Goat milk was collected for analysis of composition and MFG size. Mammary gland tissue was collected for analysis of LD diameter and proteins. The size of MFG was found to depend on LD diameter in the mammary glands of dairy goats. The regression equations for MFG size (Y) and LD diameter (x) were Y Show less
no PDF DOI: 10.3168/jds.2025-26586
LPL
Jiajun Li, Deqi Wang, Sihan Song +4 more · 2025 · Functional & integrative genomics · Springer · added 2026-04-24
Per- and polyfluoroalkyl substances (PFAS), particularly perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), are persistent environmental contaminants linked to adverse health effects, Show more
Per- and polyfluoroalkyl substances (PFAS), particularly perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), are persistent environmental contaminants linked to adverse health effects, including an increased risk of breast cancer. However, the molecular mechanisms through which PFAS contribute to breast cancer development remain poorly understood. In this study, we employed an integrated approach combining network toxicology, single-cell sequencing, spatial transcriptomics, and molecular simulation to investigate the effects of PFAS on breast cancer. By constructing a protein-protein interaction (PPI) network, we identified six core genes (PPARG, CD36, FABP4, PPARGC1A, LPL, and PCK1) that play a significant role in the development of breast cancer. These genes are involved in key cellular processes such as lipid metabolism, oxidative phosphorylation, and immune regulation, all of which are disrupted by PFAS exposure. Single-cell and spatial transcriptomic analyses revealed that these genes are predominantly expressed in endothelial, myeloid, and cancer-associated fibroblasts within the tumor microenvironment. Molecular simulation further confirmed strong binding energies between PFAS and these target proteins, suggesting direct interactions. Our findings provide novel insights into how PFAS may promote breast cancer progression at the molecular level and highlight the need for further research on environmental pollutants in cancer risk assessment and public health initiatives. Show less
📄 PDF DOI: 10.1007/s10142-025-01616-y
LPL
Ruihao Yu, Shuo Wei, Felix Kwame Amevor +7 more · 2025 · Poultry science · Elsevier · added 2026-04-24
Follicular development is tightly regulated by the coordinated action of multiple hormones and complex gene regulatory networks in granulosa cells, which play a crucial role in egg production and fert Show more
Follicular development is tightly regulated by the coordinated action of multiple hormones and complex gene regulatory networks in granulosa cells, which play a crucial role in egg production and fertility in hens. Extensive studies have established that Niemann-Pick C2 (NPC2) is a key regulator of cholesterol metabolism and steroid hormone secretion in mammals. However, its specific role in chicken ovarian granulosa cells remains unclear. In this study, cultured chicken ovarian granulosa cells were used to investigate the function of NPC2 through transfection with NPC2 overexpression vectors or small interfering RNAs (siRNAs). The results showed that silencing NPC2 significantly increased the expression of SREBP1, SREBP2, LPL, SCD1, CPT1 and DGAT2 genes involved in lipid synthesis (P < 0.01), and also increased the synthesis of Triglyceride (TG) and Cholesterol (TC) in granulosa cells (P < 0.05), whereas NPC2 overexpression led to a marked reduction in the expression of these indicators of lipid metabolism (P < 0.01). Furthermore, NPC2 knockdown significantly inhibited the production of progesterone (P Show less
📄 PDF DOI: 10.1016/j.psj.2025.105340
LPL
Shi-Shi Qin, Cai-Bo Tian, Yan-Ling Qian +4 more · 2025 · Journal of ethnopharmacology · Elsevier · added 2026-04-24
Alstonia scholaris was utilized as a medicinal herb for the management of diabetes traditionally, with diabetic nephropathy (DN) was one of its major complications. However, the effect of A. scholaris Show more
Alstonia scholaris was utilized as a medicinal herb for the management of diabetes traditionally, with diabetic nephropathy (DN) was one of its major complications. However, the effect of A. scholaris on DN have yet to be explored. To investigate the effect and mechanism of A. scholaris in treating DN. The high glucose (HG)-induced renal podocyte (MPC5) injury model was conducted in vitro, and DN mice induced by high fat diet and combined with streptozotocin (HFD + STZ) was employed to evaluate bioactivity in vivo. Transcriptome analysis was conducted to explore the potential targets of vallesamine, with findings further validated by RT-qPCR and WB analysis. Furthermore, the binding affinity of vallesamine to its potential target was investigated through molecular docking and dynamics simulation. Four major alkaloids of A. scholaris demonstrated significant efficacy in mitigating HG-induced MPC5 cell damage, and they also restored oxidation balance while reducing the release of nitric oxide and lactate dehydrogenase. Oral administration of the total alkaloids and the four compounds for 6 weeks, respectively, could ameliorate proteinuria, urinary protein-to-creatinine ratio, hyperglycemia and hyperlipidemia significantly, and as well elevate serum levels of total protein and albumin concurrently in HFD + STZ induced mice. Moreover, renal injury and matrix hyperplasia were also improved after the treatment. Notably, vallesamine (5 mg/kg) exerted a pronounced effect on DN through upregulating Ppar-δ, Fads2, Me1, Ehhadh, Lpl, Scd1, Acsl1, and downregulating Hmgcs5, Slc27a1, Dbil5 and Plin5 gene expressions of PPAR pathway. Meanwhile, proteins related to lipid metabolism (PPAR-δ and ACSL1, HMGCS2) as well as the associated with renal inflammation (PODOCIN, BCL-2, and IL-6) were regulated by vallesamine intervention. In addition, vallesamine-PPAR-δ complexes maintained structural integrity, with the binding free energy of -25.84 kJ/mol, indicating a particularly high affinity between the ligand and the receptor in molecular dynamics and docking. Total alkaloids from A. scholaris and its main components vallesamine alleviated kidney injury induced by HFD + STZ through modulation the PPAR-δ pathway, providing a potential strategy for the development of new botanical drug to treat DN. Show less
no PDF DOI: 10.1016/j.jep.2025.119839
LPL
Yamin Guo, Xinmiao Wu, Huimin Zhen +5 more · 2025 · Animals : an open access journal from MDPI · MDPI · added 2026-04-24
Our previous investigations identified miR-30a-3p as a differentially expressed miRNA in ovine mammary tissue across sheep breeds with distinct lactation performance and different physiological stages Show more
Our previous investigations identified miR-30a-3p as a differentially expressed miRNA in ovine mammary tissue across sheep breeds with distinct lactation performance and different physiological stages. However, its regulatory mechanisms controlling mammary gland development and lactation remain unexplored. In this study, the effect of miR-30a-3p on the proliferation of ovine mammary epithelial cells (MECs) and the target genes of miR-30a-3p were investigated. The regulatory effects of miR-30a-3p on the expression of the target genes and the content of triglycerides in ovine MECs were also analyzed. The transfection of miR-30a-3p mimic was found to promote cell viability and the number of proliferated ovine MECs using CCK8 and Edu assays. On the contrary, the miR-30a-3p inhibitor showed the opposite results with the miR-30a-3p mimic. These results suggest that miR-30a-3p promotes the proliferation of ovine MECs. The dual luciferase assay revealed that Phosphatase and Tensin Homolog ( Show less
📄 PDF DOI: 10.3390/ani15081180
LPL
Lei Chen, Liang Zhang, Yanni Zhao +7 more · 2025 · BMC genomics · BioMed Central · added 2026-04-24
DNA methylation plays a crucial role in species development and environmental adaptation. In mammals, there are significant dietary changes from infancy to adulthood. Notably, the red panda transition Show more
DNA methylation plays a crucial role in species development and environmental adaptation. In mammals, there are significant dietary changes from infancy to adulthood. Notably, the red panda transitions from milk consumption as juveniles to a bamboo-based diet as adults, with significant alterations in food characteristics and nutritional content. However, the regulatory role of DNA methylation in this process remains unclear. In this study, we investigate the regulatory role of DNA methylation on the expression of digestive and metabolic genes in the liver and pancreas during the red panda's dietary transition from suckling stage to adulthood. Our findings reveal significant differences in DNA methylation patterns before and after dietary transition, highlighting the specific alterations in the methylation profiles of genes involved in lipid, carbohydrate, and amino acid metabolism. We found that perilipin-4 (PLIN4) is hypomethylated and highly expressed in the liver of adult red pandas, facilitating lipid droplet formation and storage, crucial for adapting to the low-fat content in bamboo. In contrast, genes like lipoprotein lipase (LPL), crucial for lipid breakdown, exhibited hypermethylated with low-expression patterns, reflecting a reduced lipid metabolism capacity in adults. Carbohydrate metabolism-related genes like ADH4 and FAM3C are hypomethylated and highly expressed in adults, enhancing glycogen production and glucose utilization. Genes involved in protein metabolism like CTSZ and GLDC, exhibit hypomethylated with high-expression and hypermethylated with low-expression patterns in the pancreas of adults, respectively, contributing to protein metabolism balance post-weaning. This study reveals the regulatory role of DNA methylation in the dietary transition of red pandas from milk to bamboo and provides methylation evidence for the molecular regulation of adaptive expression of digestive and metabolic genes in red pandas with specialized diets. Show less
📄 PDF DOI: 10.1186/s12864-025-11606-w
LPL
Xin Zhang, Jing-Xuan Hao, Mao-Lin Cai +3 more · 2025 · Inorganic chemistry · ACS Publications · added 2026-04-24
While anticounterfeiting systems based on long persistent luminescence (LPL) materials demonstrate a mature trend, the integration of tunable luminescent lifetimes and emission colors in LPL-based ant Show more
While anticounterfeiting systems based on long persistent luminescence (LPL) materials demonstrate a mature trend, the integration of tunable luminescent lifetimes and emission colors in LPL-based anticounterfeiting systems remains a challenge. Herein, we propose a temporal and spatial anticounterfeiting strategy utilizing novel zero dimensional (0D) metal halides, specifically (PBA) Show less
no PDF DOI: 10.1021/acs.inorgchem.5c00497
LPL
Fengshuo Zhang, Zhenling Wu, Yu Zhang +5 more · 2025 · Frontiers in microbiology · Frontiers · added 2026-04-24
The objective of this study was to evaluate the effects of the dietary lysine (Lys)/ methionine (Met) ratio in a low-protein diet on short-chain fatty acid (SCFA) profiles, villus morphology, antioxid Show more
The objective of this study was to evaluate the effects of the dietary lysine (Lys)/ methionine (Met) ratio in a low-protein diet on short-chain fatty acid (SCFA) profiles, villus morphology, antioxidant capacity, and immune status of the jejunum in Tibetan sheep. A total of 90 weaned Tibetan sheep, each 2 months old with an initial weight of 15.37 ± 0.92 kg, were randomly divided into three treatment groups. These groups were supplemented with different Lys/Met ratios of 3 [low protein-high methionine (LP-H)], 2 [low protein-medium methionine (LP-M)], and 1 [low protein-low methionine (LP-L)] in the basal diet (10% crude protein). The feeding trial lasted 100 days, including a 10-day acclimation period and a 90-day experimental period. The hematoxylin-eosin (H&E) sections showed that the LP-L group had a significantly increased villus height compared to the LP-M and LP-H groups ( Collectively, our results suggest that the dietary Met/ Lys ratio could affect the jejunal SCFA concentration by modulating the microbial community and regulating metabolism, thereby contributing to jejunal barrier function. Our findings provide a theoretical basis for the application of Lys/Met diet supplementation in the nutritional management of Tibetan sheep, particularly when reducing the dietary crude protein (CP) level. Show less
📄 PDF DOI: 10.3389/fmicb.2025.1441143
LPL
Fengshuo Zhang, Zhenling Wu, Quyangangmao Su +5 more · 2025 · Food research international (Ottawa, Ont.) · Elsevier · added 2026-04-24
This study integrated the the effects of dietary Lys/Met ratio in a low protein diet on the meat quality in Tibetan sheep. A total of 90 weaned Tibetan sheep, 2 months old with initial weight of 15.37 Show more
This study integrated the the effects of dietary Lys/Met ratio in a low protein diet on the meat quality in Tibetan sheep. A total of 90 weaned Tibetan sheep, 2 months old with initial weight of 15.37 ± 0.92 kg were randomly divided into 3 treatments, which were supplemented with Lys/Met ratio at 3 (LP-H), 2 (LP-M), and 1 (LP-L) in the basal diet (10 % crude protein), respectively. After slaughter (150 days of age), the growth performances and meat quality of longissimus dorsi muscle were evaluated. The LP-L group showed significantly higher final body weight compared to the LP-M group (P < 0.05). Serum albumin and total protein levels were significantly higher in the LP-L group than in the LP-H group (P < 0.05). Furthermore, meat from the LP-L group had significantly higher protein, calcium, and vitamin E content compared to the LP-M group (P < 0.05). Transcriptomic analysis revealed 3,479 differentially expressed genes enriched in pathways related to muscle growth, energy metabolism, and signaling transduction. Metabolomic analysis identified 771 differential metabolites, significantly enriched in ABC transporters, beta-alanine metabolism, and taste transduction pathways. Integrated analysis highlighted the upregulation of the ABCD4 gene and L-valine metabolite in the LP-L group, contributing to improved phenotypic traits. These findings provide molecular insights into the regulatory mechanisms underlying the effects of dietary Lys/Met ratios on Tibetan sheep meat quality and offer a basis for developing nutritional strategies to enhance premium meat production. Show less
no PDF DOI: 10.1016/j.foodres.2025.115893
LPL
Li-Qin Meng, Pei-Ying Huang, Qing-Min Li +7 more · 2025 · Frontiers in cardiovascular medicine · Frontiers · added 2026-04-24
The efficacy and mechanism of Fufang Danshen dripping pills (FFDS) in the secondary prevention of stable coronary heart disease (SCHD) is currently undetermined. This study aims to investigate the eff Show more
The efficacy and mechanism of Fufang Danshen dripping pills (FFDS) in the secondary prevention of stable coronary heart disease (SCHD) is currently undetermined. This study aims to investigate the efficacy and preliminary mechanism by which FFDS may impact the progression of SCHD. Based on randomization, we administered oral FFDS to 30 patients with SCHD in addition to conventional treatment for 30 days. After treatment, three-months major adverse cardiovascular events (MACE) were assessed as the primary outcome. Additionally, we evaluated the patients' Seattle Angina Questionnaire score, blood pressure, circulating levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, C-reactive protein, platelets, alanine aminotransferase, aspartate aminotransferase, serum creatinine, and fasting blood glucose as the secondary outcomes. Furthermore, we utilized mass spectrometry analysis, network pharmacology, and lipidomics to predict the potential mechanisms of FFDS in the treatment of SCHD. Following treatment, FFDS demonstrated significant improvements in serum triglyceride levels ( In individuals with SCHD, the administration of FFDS has been shown to effectively reduce circulating triglyceride levels and decrease the frequency of angina episodes. This therapeutic effect is likely due to the active components of FFDS targeting key proteins: LPL, CD36, FABPpm, L-FABP, LCAT, and CEPT. https://www.chictr.org.cn/, identifier (ChiCTR2400080149). Show less
📄 PDF DOI: 10.3389/fcvm.2025.1506917
LPL
Jiahui Yang, Xiaoying Ru, Yang Huang +6 more · 2025 · Animals : an open access journal from MDPI · MDPI · added 2026-04-24
The greater amberjack (
📄 PDF DOI: 10.3390/ani15030333
LPL
Hao Zheng, Yan Li, Wen-Wen Zhan +5 more · 2025 · Angewandte Chemie (International ed. in English) · Wiley · added 2026-04-24
Copper clusters with diverse luminescent properties are of particular interest. In this study, a series of Cu
no PDF DOI: 10.1002/anie.202423787
LPL
Gayatri Arani, Amit Arora, Shuai Yang +21 more · 2025 · medRxiv : the preprint server for health sciences · Cold Spring Harbor Laboratory · added 2026-04-24
Physical activity (PA), including sedentary behavior, is associated with many diseases, including Alzheimer's disease and all-cause dementia. However, the specific biological mechanisms through which Show more
Physical activity (PA), including sedentary behavior, is associated with many diseases, including Alzheimer's disease and all-cause dementia. However, the specific biological mechanisms through which PA protects against disease are not entirely understood. To address this knowledge gap, we first assessed the conventional observational associations of three self-reported and three device-based PA measures with circulating levels of 2,911 plasma proteins measured in the UK Biobank (n Show less
📄 PDF DOI: 10.1101/2025.01.16.25320290
LPL
Bohan Su, Zhiyao Fan, Jiexi Wu +1 more · 2025 · Scientific reports · Nature · added 2026-04-24
Previous studies have found that dyslipidemia is a risk factor for pancreatic cancer (PC), and that lipid-lowering drugs may reduce the risk of PC. However, it is not clear whether dyslipidemia causes Show more
Previous studies have found that dyslipidemia is a risk factor for pancreatic cancer (PC), and that lipid-lowering drugs may reduce the risk of PC. However, it is not clear whether dyslipidemia causes PC. The Mendelian randomization (MR) study aimed to investigate the causal role of lipid traits in pancreatic cancer and to assess the potential impact of lipid-lowering drug targets on pancreatic cancer. Genetic variants associated with lipid traits and variants of genes encoding lipid-lowering drug targets were extracted from the Global Lipids Genetics Consortium genome-wide association study (GWAS). Summary statistics for PC were obtained from an independent GWAS datasets. Colocalization analyses were performed to validate the robustness of the results. No significant effect of lipid-lowering drug targets on PC risk was found. Genetic mimicry of lipoprotein lipase (LPL) was potentially associated with PC risks. Significant MR associations were observed in the discovery dataset (OR 1.64 [95% CI 1.24-2.16], p = 4.48*10 Show less
📄 PDF DOI: 10.1038/s41598-025-87490-x
LPL
Pan Zhang, Xiaohui Zhao, Zhenwei Jia +10 more · 2025 · Advanced materials (Deerfield Beach, Fla.) · Wiley · added 2026-04-24
With the development of optical anti-counterfeiting and the increasing demand for high-level information encryption, multimodal luminescence (MML) materials attract much attention. However, the discov Show more
With the development of optical anti-counterfeiting and the increasing demand for high-level information encryption, multimodal luminescence (MML) materials attract much attention. However, the discovery of these multifunctional materials is very accidental, and the versatile host suitable for developing such materials remains unclear. Here, a grossite-type fast ionic conductor CaGa Show less
no PDF DOI: 10.1002/adma.202411532
LPL
Juan Li, Huai Wei, Ning Wang +6 more · 2025 · Biological trace element research · Springer · added 2026-04-24
In recent years, the concentration of PM
no PDF DOI: 10.1007/s12011-024-04386-z
LPL
Jieyu Liu, Zhuohui Chen, Ziwei Teng +8 more · 2025 · Journal of affective disorders · Elsevier · added 2026-04-24
This study aimed to investigate serum inflammatory factor levels of polycystic ovary syndrome (PCOS) in female patients with bipolar disorder (BD) to explore the related inflammatory molecular mechani Show more
This study aimed to investigate serum inflammatory factor levels of polycystic ovary syndrome (PCOS) in female patients with bipolar disorder (BD) to explore the related inflammatory molecular mechanisms preliminarily. The study recruited 72 female drug-naïve patients with BD and 98 female healthy controls (HCs). Demographic information, menstrual cycles, sex hormone levels, and ovarian ultrasound data were collected from them. Additionally, their serum inflammatory factor levels and the proteomics of peripheral blood mononuclear cells were analyzed. The levels of interleukin (IL)-8 and IL-13 were significantly higher in patients with BD than in HCs (p < 0.05), and the IL-8 level was higher in BD patients with PCOS than in those without (adjusted p = 0.07). Bioinformatics analysis revealed that downregulated genes with significant differences between the two groups were all involved in immune-inflammatory-related pathways, and the expression of downregulated genes BTN3A2, MAP2K5, JCHAIN-B, and DMAP1 showed substantial differences and consistent trends between the two groups. IL-8-related chronic inflammatory response is closely associated with PCOS in BD patients, and genes such as BTN3A2 may mediate this chronic inflammatory response by negatively regulating the abnormal differentiation of T helper 17 cells, serving as one of the mechanisms underlying its pathogenesis. Show less
no PDF DOI: 10.1016/j.jad.2025.02.072
MAP2K5
Cheng-Sen Cai, Zhen Yao, Ming-Zhu Xu +3 more · 2025 · Zhongguo shi yan xue ye xue za zhi · added 2026-04-24
To investigate the clinical characteristics and prognostic of venetoclax (VEN) combined targeted therapy in acute leukemia (AL) patients with A retrospective analysis was conducted on 16 Among the 16 Show more
To investigate the clinical characteristics and prognostic of venetoclax (VEN) combined targeted therapy in acute leukemia (AL) patients with A retrospective analysis was conducted on 16 Among the 16 cases, 3 were confirmed by reverse transcription multiplex PCR, and 13 were detected through targeted RNA-seq among 528 AL patients, with a detection rate of 2.46%. The averge age of patients was (28.0±8.58) years. Patients exhibited diverse immunophenotypes, including 7 cases of acute myeloid leukemia, 5 of acute T-lymphoblastic leukemia, 1 of acute B-lymphoblastic leukemia, 1 of acute undifferentiated leukemia, and 2 of mixed-phenotype acute leukemia. Among them, 11 had extramedullary disease (EMD), 14 expressed CD7, and 12 expressed CD33. Major co-occurring mutations included Show less
no PDF DOI: 10.19746/j.cnki.issn.1009-2137.2025.03.013
MLLT10
Ting Li, Ping Wu, Man Chen +3 more · 2025 · Cytometry. Part B, Clinical cytometry · Wiley · added 2026-04-24
no PDF DOI: 10.1002/cyto.b.22243
MLLT10
J Xia, X H Hu, Y Zhao +4 more · 2025 · Zhonghua nei ke za zhi · added 2026-04-24
A retrospective analysis of clinical data of 8 patients with PICALM::MLLT10 (P/M) fusion gene-positive acute myeloid leukemia (AML) diagnosed by transcriptome sequencing (RNA-seq) at the First Affilia Show more
A retrospective analysis of clinical data of 8 patients with PICALM::MLLT10 (P/M) fusion gene-positive acute myeloid leukemia (AML) diagnosed by transcriptome sequencing (RNA-seq) at the First Affiliated Hospital of Soochow University from June 2017 to March 2023 was performed. Laboratory findings and treatment status were analyzed, and survival analysis was performed using the Kaplan-Meier method. The 8 patients included 5 males and 3 females, aged 16-35 years, with a median age of 27 years. The platelet count of patients was normal, and 3 patients had mild to moderate anemia. Extramedullary infiltration was present in all patients with clinical manifestations, including 5 patients with mediastinal masses, 2 patients with hepatosplenomegaly, 1 patient with central nervous system leukemia, and 1 patient with cervical lymph node enlargement. Karyotypical analysis revealed 7 patients with an abnormal karyotype, including 6 cases of complex karyotypes. Of these, 4 patients harbored the t(10;11) translocation. The complete remission rate of induction chemotherapy in the patients was 7/8, and 2 patients experienced early recurrence. All patients subsequently underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT), The follow-up period ranged from 86 to 812 days, with a median of 330 days. Among the 8 patients, 3 survived and 5 died due to recurrence. Relapse and death only occurred in the P/M fusion gene-positive patients after transplantation. The overall survival rate at 1 year after transplantation was 37.5%. P/M Show less
no PDF DOI: 10.3760/cma.j.cn112138-20240913-00577
MLLT10
Xueya Zhang, Jinfa Zhong, Yuqi Sun +1 more · 2025 · Cytometry. Part B, Clinical cytometry · Wiley · added 2026-04-24
no PDF DOI: 10.1002/cyto.b.22214
MLLT10
Vinod Tiwari, Byungchang Jin, Olivia Sun +9 more · 2025 · Nature metabolism · Nature · added 2026-04-24
Citrin deficiency (CD) is caused by the inactivation of SLC25A13, a mitochondrial membrane protein required to move electrons from cytosolic NADH to the mitochondrial matrix in hepatocytes. People wit Show more
Citrin deficiency (CD) is caused by the inactivation of SLC25A13, a mitochondrial membrane protein required to move electrons from cytosolic NADH to the mitochondrial matrix in hepatocytes. People with CD do not like sweets. Here we show that SLC25A13 loss causes the accumulation of glycerol-3-phosphate (G3P), which activates the carbohydrate response element-binding protein (ChREBP) to transcribe FGF21, which acts in the brain to restrain intake of sweets and alcohol and to transcribe key genes driving lipogenesis. Mouse and human data suggest that G3P-ChREBP is a mechanistic component of the Randle Cycle that contributes to metabolic-dysfunction-associated steatotic liver disease and forms part of a system that communicates metabolic states from the liver to the brain in a manner that alters food and alcohol choices. The data provide a framework for understanding FGF21 induction in varied conditions, suggest ways to develop FGF21-inducing drugs and suggest potential drug candidates for lean metabolic-dysfunction-associated steatotic liver disease and support of urea cycle function in CD. Show less
📄 PDF DOI: 10.1038/s42255-025-01399-3
MLXIPL
Xiao-Yuan Wu, Ning Ren, Jie Geng · 2025 · Frontiers in cardiovascular medicine · Frontiers · added 2026-04-24
Hypertrophic cardiomyopathy (HCM) represents the most prevalent form of hereditary cardiomyopathy, and mutation in the cardiac myosin-binding protein C (MYBPC3) gene have been identified as a major co Show more
Hypertrophic cardiomyopathy (HCM) represents the most prevalent form of hereditary cardiomyopathy, and mutation in the cardiac myosin-binding protein C (MYBPC3) gene have been identified as a major contributor to the pathogenesis of HCM. While the desmoplakin (DSP) gene is primarily associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM), its role in HCM has been less frequently documented. This case report describes a Chinese patient with obstructive HCM harboring rare variants in both the MYBPC3 and DSP genes. These findings provide valuable insights for future investigations into the genetic underpinnings and disease associations. Show less
📄 PDF DOI: 10.3389/fcvm.2025.1630263
MYBPC3
Shuenn-Nan Chiu, Jyh-Ming Jimmy Juang, Wei-Chieh Tseng +7 more · 2025 · Heart rhythm O2 · Elsevier · added 2026-04-24
Sudden cardiac arrest (SCA) is a leading cause of death in pediatric hypertrophic cardiomyopathy (HCM). The study sought to analyze the clinical and genetic characteristics of pediatric HCM and assess Show more
Sudden cardiac arrest (SCA) is a leading cause of death in pediatric hypertrophic cardiomyopathy (HCM). The study sought to analyze the clinical and genetic characteristics of pediatric HCM and assess the applicability of current SCA risk prediction models. We enrolled individuals diagnosed as HCM before 20 years of age, between 2000 and 2020, excluding those secondary to hemodynamic causes and those associated with genetic syndromes other than RASopathies. Among 91 patients (31 female, 60 male), SCA occurred in 13 (14.3%) patients, with 6 (46%) cases presenting as the initial symptom. These 6 patients were older and had lower left ventricular mass In pediatric HCM, SCA is notably associated with sarcomere gene pathogenic variants. While newer risk scoring systems, if incorporated with genetic information, effectively predict SCA in this Asia cohort, a challenge remains: nearly half of SCA cases present as the initial clinical manifestation. Show less
📄 PDF DOI: 10.1016/j.hroo.2025.03.022
MYBPC3
Teng Wu, Tongsheng Huang, Honglin Ren +26 more · 2025 · Circulation research · added 2026-04-24
Individuals with diabetes are susceptible to cardiac dysfunction and heart failure, potentially resulting in mortality. Metabolic disorders frequently occur in patients with diabetes, and diabetes usu Show more
Individuals with diabetes are susceptible to cardiac dysfunction and heart failure, potentially resulting in mortality. Metabolic disorders frequently occur in patients with diabetes, and diabetes usually leads to remodeling of heart structure and cardiac dysfunction. However, the contribution and underlying mechanisms of metabolic and structural coupling in diabetic cardiac dysfunction remain elusive. Two mouse models of type 2 diabetes (T2DM) were used to assess alterations in glucose/lipid metabolism and cardiac structure. The potential metabolic-structural coupling molecule ACBP (acyl-coenzyme A-binding protein) was screened from 4 published datasets of T2DM-associated heart disease. In vivo loss-of-function and gain-of-function approaches were used to investigate the role of ACBP in diabetic cardiac dysfunction. The underlying mechanisms of metabolic and structural coupling were investigated by stable-isotope tracing metabolomics, coimmunoprecipitation coupled with mass spectrometry, and chromatin immunoprecipitation sequencing. Diabetic mouse hearts exhibit enhanced lipid metabolism and impaired ultrastructure with marked cardiac systolic and diastolic dysfunction. Analysis of 4 T2DM public datasets revealed that Our findings demonstrated that ACBP mediates the bidirectional regulation of cardiomyocyte metabolic and structural associations and identified a promising therapeutic target for ameliorating cardiac dysfunction in patients with T2DM. Show less
no PDF DOI: 10.1161/CIRCRESAHA.124.326044
MYBPC3
Yupeng Wu, Yuzhu Zhang, Qirui Zheng +5 more · 2025 · Frontiers in cardiovascular medicine · Frontiers · added 2026-04-24
Mutations in the sarcomere protein, particularly in cardiac myosin binding protein C gene ( We used multi-omics approaches and super-resolution imaging to explore the effects of MyBPC3 P459fs mutation Show more
Mutations in the sarcomere protein, particularly in cardiac myosin binding protein C gene ( We used multi-omics approaches and super-resolution imaging to explore the effects of MyBPC3 P459fs mutation on humans and cells. HCM patients carrying MyBPC3 P459fs mutation (MyBPC3-P459fs HCMs) and healthy controls (HCs) were evaluated for myocardial function using both conventional and advanced echocardiography. In parallel, H9C2 myocardial cells infected with either MyBPC3 P459fs mutation (P459fs cells) or its wild type (WT cells) were investigated for myocardial fiber formation and the potential pathways behind this using super-resolution imaging and metabolomics and proteomics. First, conventional and advanced echocardiography showed that MyBPC3-P459fs HCMs exhibited left ventricular diastolic and systolic dysfunction. Subsequently, super-resolution imaging indicated that P459fs cells formed fewer and shorter myocardial fibers in the cytoplasm compared to WT cells. Moreover, our metabolomic and proteomic data suggested several key components of mitochondrial membrane integrity, myocardial remodeling, myocardial energy metabolism, oxidative stress, inflammation, and actin binding capacity were significantly altered in response to P459fs mutation. This investigation indicated myocardial dysfunction and myocardial fiber disarray in clinical HCMs with MyBPC3 P459fs mutation and added potential pathways underlying this. These findings provided a link between the observed structural and functional disorders in MyBPC3 P459fs mutation and its onset of HCM pathogenesis and might have a significant translational contribution to effective treatment in HCM patients with MyBPC3 P459fs mutation. Show less
📄 PDF DOI: 10.3389/fcvm.2025.1529921
MYBPC3
Meiling Sheng, Qunzhi Wang, Yabo Lou +2 more · 2025 · Physiological genomics · added 2026-04-24
The elusive function of myosin light chain 9 (MYL9) in cancer is an area ripe for further investigation. Bioinformatics was used to compare the expression levels of MYL9 in non-small-cell lung cancer Show more
The elusive function of myosin light chain 9 (MYL9) in cancer is an area ripe for further investigation. Bioinformatics was used to compare the expression levels of MYL9 in non-small-cell lung cancer (NSCLC) and normal tissues. Gene set enrichment analysis was used to investigate the pathways associated with MYL9. The BioGRID database was used to screen for potential targets of MYL9. The expression of MYL9 and myosin 19 (MYO19) mRNA was quantified using quantitative reverse transcriptase PCR. Cell migration was assessed using a scratch wound healing assay. The protein levels of MYL9, MYO19, and epithelial-mesenchymal transition (EMT) biomarkers were examined using Western blot (WB). Epithelial cell adhesion molecule (EpCAM) expression in different cell groups was profiled using flow cytometry analysis. Coimmunoprecipitation assays were performed to determine the binding affinity between MYL9 and MYO19. In addition, the direct protein interaction between MYL9 and MYO19 was explored using a glutathione-S-transferase (GST) pull-down assay. In NSCLC patients, MYL9 was significantly downregulated both in vivo and in cell cultures and had a high enrichment score in the EMT pathway. Scratch assays pointed to its inhibitory effect on cancer cell migration. WB showed that MYL9 could suppress EMT marker protein expression in NSCLC cells. Flow cytometry found that MYL9 greatly reduced the distribution of EpCAM on the cell surface. MYO19 was pinpointed as a potential target of MYL9, as confirmed by coimmunoprecipitation and GST pull-down assays. Rescue experiments confirmed that MYO19 could enhance cell migration, promote the expression of EMT markers, and increase EpCAM levels on the cell surface, but these effects were reserved by MYL9 overexpression. MYL9 impedes the migration and EMT in NSCLC cells by binding to MYO19. Show less
no PDF DOI: 10.1152/physiolgenomics.00119.2024
MYO19